세계의 무수정체안 시장 규모 : 유형별, 치료별, 최종사용자별, 지역별, 범위 및 예측

Aphakia Market Size And Forecast

Aphakia Market size was valued at USD 1.83 Billion in 2024 and is projected to reach USD 4.30 Billion by 2031, growing at a CAGR of 11.3% during the forecast period 2024-2031. The market is growing as a result of the aging population, the quickly growing healthcare industry, and the rising demand for better ocular disease treatment. The Global Aphakia Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Aphakia Market Definition

Aphakia is a condition in which a person's eye is missing its natural lens, either because it was surgically removed or because it was never present at birth. The lens is the transparent structure inside the eye that helps to focus light onto the retina at the back of the eye. Without a lens, vision can be severely impaired, causing significant visual problems. Aphakia can result from various causes, including cataract surgery, congenital absence of the lens, trauma, or infection.

When the natural lens is removed surgically, an artificial lens can be implanted to replace it. However, in some cases, such as with congenital aphakia, an artificial lens may not be an option, and the person may need to rely on corrective lenses or other devices to improve their vision. People with aphakia often have significant refractive errors, such as high degrees of nearsightedness or farsightedness, and astigmatism.

Corrective lenses, such as glasses or contact lenses, are often prescribed to help improve vision. In some cases, a special type of contact lens called an aphakic lens may be recommended, which is designed to compensate for the lack of a natural lens. While vision can be significantly affected by aphakia, many people with the condition are able to lead normal, productive lives with the help of corrective lenses or other devices. Regular eye exams are important for people with aphakia to monitor their vision and ensure that their corrective lenses are up to date.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Aphakia Market Overview

The Aphakia Market refers to the industry that provides products and services related to the treatment of the condition known as aphakia, in which a person's natural lens is missing from their eye. The market includes products such as corrective lenses, artificial lenses, and other devices that can help improve vision in people with aphakia. The market for aphakia treatment is primarily driven by the increasing prevalence of cataract surgery, which is the most common cause of aphakia.

As the population ages and the number of cataract surgeries performed increases, the demand for products and services related to aphakia treatment is expected to grow. The market for aphakia treatment is also driven by the increasing availability of advanced technology and innovative products. For example, the development of new types of artificial lenses, such as intraocular lenses (IOLs), has improved the outcomes of cataract surgery and provided new options for people with aphakia.

Overall, the Aphakia Market is expected to continue to grow in the coming years as the demand for treatment options for aphakia and related conditions increases. New innovations and advancements in technology are likely to drive the market forward, providing new options and opportunities for people with aphakia to improve their vision and quality of life.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Aphakia Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter's Five Forces

The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Aphakia Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Global Aphakia Market Segmentation Analysis

The Global Aphakia Market is segmented on the basis of Type, Treatment, End User, and Geography.

Aphakia Market, By Type

• Congenital Aphakia
• Surgical Aphakia
• Acquired Aphakia

Based on Type, the Aphakia Market is segmented into Congenital Aphakia, Surgical Aphakia, and Acquired Aphakia. Acquired Aphakia is a condition brought on by the absence of eye lenses. This disorder can affect people of any age, but it usually develops as a result of an accident, a procedure, or an illness such as osteogenesis imperfecta or glaucoma. Patients without a lens or its remnant are reported to have this kind of aphakia. Double vision and hazy vision are two of the signs of this type, while additional signs include cataract surgery, refractive surgery, etc.

Aphakia Market, By Treatment

• Spectacles
• Contact Lenses
• Intraocular Lens Implantation
• Refractive Surgery

Based on Treatment, the Aphakia Market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation, and Refractive Surgery. When the natural lens of an eye gets foggy and cannot be corrected by regular glasses, aphakia is employed. This allows for a clean vision of objects that are different distances from the eyes. Once such treatment has been received, an aphakia patient will no longer require the use of any extra reading or near-vision lenses.

Aphakia Market, By End User

• Hospitals
• Ophthalmic clinics
• Others

Based on End User, the Aphakia Market is segmented into Hospitals, Ophthalmic clinics, and Others.

Aphakia Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• On the basis of Regional Analysis, The Global Aphakia Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Due to the rising prevalence of aphakia cases, advanced technology, the region's sizable diabetic population, and increased government funding for R&D, North America dominates the global aphakia industry. Because of its substantial and fast-expanding economy, sizable patient pool, rising frequency of ocular illnesses, and rapidly rising elderly population, Asia-Pacific is predicted to develop at a significant growth rate in the forecast period.

Key Players

• The "Global Aphakia Market" study report will provide valuable insight with an emphasis on the Global market including some of the major key players such as
• Johnson & Johnson Services, Inc., Ophtec BV, Novartis AG, Bausch Health, ZEISS International, Rayner Intraocular Lenses Limited, Aetna Inc., CooperVision, Menicon Co., Ltd., Labtician Ophthalmics, Inc., and Others.

Our market analysis contains a section exclusively devoted to such significant firms, where our experts provide a summary of each company's financial statements as well as product benchmarking and SWOT analysis. The competitive landscape section also includes the key development strategies, market share analysis, and market positioning analysis of the aforementioned competitors internationally.

Key Developments

• In July 2022, Intraocular lenses (IOLs) from the Clareon(R)family have been made available in the United States, according to Alcon (SIX/NYSE: ALC), a leader in eye care around the world committed to enabling people to see brilliantly. The most cutting-edge IOL material from Alcon allows Clareon to produce consistently excellent visual results and long-lasting clarity. 1-7 When compared to the leading competitor IOLs, the glistening-free IOL material used in Clareon has some of the lowest levels of haze and subsurface nanoglistenings (SSNGs).
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
• Active, Cutting Edge, Emerging, and Innovators.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL APHAKIA MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL APHAKIA MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL APHAKIA MARKET, BY TYPE

• 5.1 Overview
• 5.2 Congenital Aphakia
• 5.3 Surgical Aphakia
• 5.4 Acquired Aphakia

6 GLOBAL APHAKIA MARKET, BY TREATMENT

• 6.1 Overview
• 6.2 Spectacles
• 6.3 Contact Lenses
• 6.4 Intraocular Lens Implantation
• 6.5 Refractive Surgery

7 GLOBAL APHAKIA MARKET, BY END USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ophthalmic Clinics
• 7.4 Others

8 GLOBAL APHAKIA MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL APHAKIA MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Johnson & Johnson Services, Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Ophtec BV
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Novartis AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Bausch Health
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 ZEISS International.
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Rayner Intraocular Lenses Limited
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Aetna Inc.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 CooperVision
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Menicon Co.Ltd.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Labtician Ophthalmics, Inc.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research